Major pharmaceutical residues in wastewater treatment plants and receiving waters in Bangkok, Thailand, and associated ecological risks.

Pharmaceuticals have been frequently detected in aquatic environment worldwide and suspected for potential ecological consequences. However, occurrences, sources and potential risks of pharmaceutical residues have rarely been investigated in Bangkok, Thailand, one of most densely populated cities in the world. We collected water samples from five wastewater treatment plants (WWTPs), six canals, and in mainstream Chao Phraya River of Bangkok, in three sampling events representing different seasonal flow conditions, i.e., June and September 2011 and January 2012. Fourteen major pharmaceuticals including acetaminophen, acetylsalicylic acid, atenolol, caffeine, ciprofloxacin, diclofenac, ibuprofen, mefenamic acid, naproxen, roxithromycin, sulfamethazine, sulfamethoxazole, sulfathiazole and trimethoprim were analyzed. Levels of pharmaceutical residues in WWTP influents on average were the highest for acetylsalicylic acid (4700 ng L(-1)), followed by caffeine (2250 ng L(-1)) and ibuprofen (702 ng L(-1)). In effluents, the concentration of caffeine was the highest (307 ng L(-1)), followed by acetylsalicylic acid (261 ng L(-1)) and mefenamic acid (251 ng L(-1)). In surface water, acetylsalicylic acid showed the highest levels (on average 1360 ng L(-1) in canals and 313 ng L(-1) in the river). Removal efficiencies of WWTPs for roxithromycin, sulfamethoxazole and sulfamethazine were determined negligible. For several compounds, the concentrations in ambient water were higher than those detected in the effluents, implying contribution of the WWTPs to be negligible. Hazard quotients estimated for acetylsalicylic acid, ciprofloxacin, diclofenac and mefenamic acid in most of the canals and that of ciprofloxacin in the river, were greater than or close to 1, suggesting potential ecological risks. Ecological implications of the pharmaceutical residues in Bangkok waterway warrant further investigation.

[1]  Kyungho Choi,et al.  Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea. , 2008, The Science of the total environment.

[2]  M. Birkved,et al.  Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. , 2000, Chemosphere.

[3]  Richard M. Dinsdale,et al.  The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.

[4]  G. Ying,et al.  Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China. , 2010, The Science of the total environment.

[5]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[6]  Marta Carballa,et al.  Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. , 2004, Water research.

[7]  Oliver A.H. Jones,et al.  Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. , 2002, Water research.

[8]  E. Michael Thurman,et al.  Response to Comment on “Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999−2000: A National Reconnaissance” , 2002 .

[9]  J. Bayona,et al.  Removal of pharmaceuticals and personal care products (PPCPs) from urban wastewater in a pilot vertical flow constructed wetland and a sand filter. , 2007, Environmental science & technology.

[10]  Ji-feng Yang,et al.  Occurrence and a screening‐level risk assessment of human pharmaceuticals in the Pearl River system, South China , 2010, Environmental toxicology and chemistry.

[11]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[12]  C. Metcalfe,et al.  Pharmaceuticals and Endocrine Disruptors in Wastewater Treatment Effluents and in the Water Supply System of Calgary, Alberta, Canada , 2006 .

[13]  Jaeweon Cho,et al.  Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. , 2007, Water research.

[14]  J. Sekizawa,et al.  Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. , 2007, Environmental sciences : an international journal of environmental physiology and toxicology.

[15]  R. Jindal,et al.  Pharmaceutical Residues in Wastewater Treatment Plants and Surface Waters in Bangkok , 2012 .

[16]  A. Spongberg,et al.  Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. , 2008, The Science of the total environment.

[17]  D. Barceló,et al.  Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. , 2009, Analytical chemistry.

[18]  Cheng-Fang Lin,et al.  Pharmaceutical contamination in residential, industrial, and agricultural waste streams: risk to aqueous environments in Taiwan. , 2008, Chemosphere.

[19]  Kyungho Choi,et al.  Occurrences and ecological risks of roxithromycin, trimethoprim, and chloramphenicol in the Han River, Korea , 2008, Environmental toxicology and chemistry.

[20]  T. Ginn,et al.  Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. , 2005, Journal of hazardous materials.

[21]  P. Jjemba Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. , 2006, Ecotoxicology and environmental safety.

[22]  M. Petrovíc,et al.  Occurrence and Elimination of Pharmaceuticals During Conventional Wastewater Treatment , 2012 .

[23]  T. Heberer Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.

[24]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[25]  Y. Tsai,et al.  Fate of selected pharmaceuticals and personal care products after secondary wastewater treatment processes in Taiwan. , 2010, Water science and technology : a journal of the International Association on Water Pollution Research.

[26]  Klaus Kümmerer,et al.  Antibiotics in the aquatic environment--a review--part I. , 2009, Chemosphere.

[27]  J. Giesy,et al.  Effects of sulfathiazole, oxytetracycline and chlortetracycline on steroidogenesis in the human adrenocarcinoma (H295R) cell line and freshwater fish Oryzias latipes. , 2010, Journal of hazardous materials.

[28]  D. Barceló,et al.  Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. , 2006, Talanta.

[29]  A. Lin,et al.  Removal of pharmaceuticals in secondary wastewater treatment processes in Taiwan. , 2009, Journal of hazardous materials.

[30]  Jeong-Eun Oh,et al.  Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. , 2010, Environmental pollution.

[31]  E. C. Vasconcelos,et al.  Environmental risk assessment of antibiotics: an intensive care unit analysis. , 2009, Chemosphere.

[32]  D G Joakim Larsson,et al.  Effluent from bulk drug production is toxic to aquatic vertebrates , 2009, Environmental toxicology and chemistry.

[33]  Adriano Joss,et al.  Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. , 2007, The Science of the total environment.

[34]  Marta Carballa,et al.  How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters? , 2008 .

[35]  Kyungho Choi,et al.  Pharmaceuticals and Personal Care Products in the Environment: What Are the Big Questions? , 2012, Environmental health perspectives.

[36]  Xiu-Sheng Miao,et al.  Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada. , 2004, Environmental science & technology.